title: [Mepenam application for prophylaxis and treatment of purulent complications of an acute destructive pancreatitis].
abstract: The experience of meropenem (Mepenam, manufactured by 'Arterium", Ukraine Corporation) application as a measure for conduction of empirical therapy and for prophylaxis of an acute destructive pancreatitis complications, was summarized. Efficacy of the preparation on different stages of the purulent complications treatment (while applied solely as well as in combination with various kinds of miniinvasive and open operative interventions) was estimated. The recommendations, concerning Mepenam application for various forms of an acute pancreatitis, were elaborated.
authors.forename: M Iu
authors.initials: MIu
authors.lastname: Nychytaĭlo
authors.forename: I I
authors.initials: II
authors.lastname: Bulyk
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D000077731:Meropenem; D019283:Pancreatitis, Acute Necrotizing / Q000188:drug therapy* / Q000382:microbiology*; D013845:Thienamycins / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D013845:Thienamycins; D000077731:Meropenem